Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled Trial

Abstract
In a randomized trial conducted in 27 intensive care units, we compared the clinical efficacy and safety of piperacillin-tazobactam (TAZ; 4 g/0.5 g q

This publication has 0 references indexed in Scilit: